Personalized, multivalent, and more affordable: the globalization of vaccines.
Debinski
Waldemar
W
D001932:Brain Neoplasms / Q000188:drug therapy / Q000276:immunology*; D019496:Cancer Vaccines / Q000191:economics / Q000276:immunology* / Q000627:therapeutic use; D005910:Glioma / Q000188:drug therapy / Q000276:immunology*; D015234:HLA-A Antigens / Q000276:immunology; D015789:HLA-A2 Antigen / Q000276:immunology; D059871:HLA-A24 Antigen; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology; D010455:Peptides / Q000276:immunology* / Q000627:therapeutic use; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D016896:Treatment Outcome
D019496:Cancer Vaccines; D015234:HLA-A Antigens; D015789:HLA-A2 Antigen; D059871:HLA-A24 Antigen; D010455:Peptides